Kenneth Seres, MD
Gastroenterology · Oklahoma City, OKNPI 1871633404
Payments from drug & device makers
Across 634 payments — averaging $39.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$16K
- AbbVie$3K
- Johnson & Johnson$975
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$820
- Takeda Pharmaceuticals U.S.A., Inc.$700
- Pfizer$346
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 3 | $15,650 |
| AbbVie | 215 | $3,407 |
| Johnson & Johnson | 80 | $975 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 67 | $820 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $700 |
| Pfizer | 24 | $346 |
| Bristol Myers Squibb | 22 | $284 |
| Gilead | 19 | $227 |
| Nestle Healthcare Nutrition Inc. | 12 | $223 |
| QOL Medical, LLC | 16 | $216 |
| Daiichi Sankyo Inc. | 10 | $204 |
| Merck | 14 | $188 |
| Braintree Laboratories, Inc. | 9 | $177 |
| Ardelyx, Inc. | 9 | $176 |
| Ironwood Pharmaceuticals, Inc | 11 | $169 |
| Sanofi | 10 | $163 |
| Regeneron Healthcare Solutions, Inc. | 9 | $159 |
| Ferring Pharmaceuticals Inc. | 7 | $124 |
| Redhill Biopharma Inc. | 8 | $120 |
| UCB, Inc. | 7 | $105 |
| Lilly USA, LLC | 4 | $97 |
| Shire North American Group Inc | 5 | $95 |
| AstraZeneca | 3 | $89 |
| Intercept Pharmaceuticals, Inc. | 4 | $58 |
| Pharmacosmos Therapeutics Inc. | 3 | $54 |
| Amgen | 3 | $44 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| AMAG Pharmaceuticals, Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| Mallinckrodt Hospital Products Inc. | 2 | $30 |
| Celltrion USA Inc. | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Romark Laboratories, LC | 2 | $15 |
| Bausch Health US, LLC | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
How this compares
$25,087 in reported general payments places this provider in the 80th percentile of 133 gastroenterology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Oklahoma City
- Tauseef AliOklahoma City$2.1M
- David StokesberryOklahoma City$1.7M
- George SalemOklahoma City$1.2M
- Matthew McBrideOklahoma City$741K
- Richard HartyOklahoma City$462K
- Hussein BitarOklahoma City$184K
- Neil CrittendenOklahoma City$143K
- Pooja SinghalOklahoma City$140K
- Trushar PatelOklahoma City$49K
- Sumit WaliaOklahoma City$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.